Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Open-label Study of Visilizumab for Treatment of Perianal Fistulas in Patients With Crohn's Disease

NCT00267709 is registered in ClinicalTrials.gov with Facet Biotech as lead sponsor.

NCT NCT00267709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00267709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Open-label Study of Visilizumab for Treatment of Perianal Fistulas in Patients With Crohn's Disease
Lead sponsor
Facet Biotech
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2005
Completion date
December 31, 2006
Enrollment
18
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease